fbpx

U.S. Anti-Doping Agency (USADA)

Global DRO logo in whiteSearch Medications & Ingredients

Athlete Login >

GlobalDRO >
Medication Search >

US Paralympic Track & Field Athlete, Madsen, Accepts Public Warning For Anti-Doping Rule Violation

June 22, 2012

USADA announced today that Angela Madsen of Long Beach, California, an athlete in the sport of Paralympic Track & Field, has tested positive for a prohibited substance and has accepted a public warning and loss of results from May 19, 2012, for her anti-doping rule violation.

Madsen, 52, provided a urine sample on May 19, 2012, at the Desert Challenge that resulted in an adverse analytical finding for Fentanyl, which is in the class of narcotics prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Paralympic Committee (IPC) anti-doping rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List.

Although the substance is prohibited under the applicable rules, an athlete who provides documentation confirming the diagnosis of a valid medical need, may receive a Therapeutic Use Exemption (“TUE”). After Madsen provided her urine sample, she was granted a TUE for Fentanyl by USADA. Under the applicable rules, athletes are to have obtained a TUE prior to using prohibited substances in order to avoid an anti-doping rule violation.

As a result of the anti-doping rule violation, Madsen is disqualified from all competitive results obtained on or since May 19, 2012, when her sample was collected, including forfeiture of any medals, points and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

Scroll to Top